| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $729.6M | +3.4% |
| Gross Profit | $213.1M | +4.6% |
| R&D Expense | $1.1M | -35.1% |
| SG&A Expense | $156.4M | -6.2% |
| Operating Income | $39.8M | +2191.7% |
| Pre-tax Income | $24.2M | +229.9% |
| Income Tax | $5.3M | +532.3% |
| Net Income | $19.0M | +208.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | +3.8% |
| Accounts Receivable | $127.3M | -4.2% |
| Inventory | $14.5M | -5.2% |
| Current Assets | $172.5M | -4.4% |
| Total Assets | $523.0M | -2.2% |
| Current Liabilities | $114.9M | -1.4% |
| Long-term Debt | $169.6M | -10.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.1M | +87.4% |
| Capital Expenditures | $17.9M | -14.2% |
| Investing Cash Flow | -$21.4M | +3.5% |
| Financing Cash Flow | -$27.4M | -255.5% |
| Free Cash Flow | $32.2M | +446.8% |
| Total Liabilities |
| $324.1M |
| -5.8% |
| Stockholders' Equity | $198.6M | +4.4% |